EBRO 2017

Conclusion (2)

• Prognostic factors stronger than treatment • weight loss (50% at diagnosis) • performance status (40% at diagnosis) • TN stage (PET) • Better staging, better treatment • high incidence of metastasis at diagnosis • role of PET/CT • Co-existent diseases • tobacco